Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.
Also called NCT01092130
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 101 participants
- Registry
-
NCT01092130
-
- Other papers using this trial's data
- Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT01092130. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2012-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure
- Acronym
- VitD-CHF
- Condition
- Chronic Heart Failure
- Intervention (Drug)
- Vitamin D
- Lead sponsor
- University Medical Center Groningen
- Collaborator
- Netherlands Foundation for Cardiovascular Excellence
Record details
- Record id
cardio:ct-nct01092130- Content hash
ad43c36d4e8f1d7ee87757b30954f6cb5949e0810e6a00c4a97d3f6cdffe4134